IBB

iShares NASDAQ Biotechnology ETF
A

76
  • Overview
  • Efficiency
  • Tradability
  • Fit

IBB Fund Description

The iShares NASDAQ Biotechnology ETF tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

IBB Factset Analytics Insight

The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.

IBB MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of November 21, 2017 the iShares NASDAQ Biotechnology ETF MSCI ESG Fund Quality Score is 4.42 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. IBB ranks in the 22nd percentile within its peer group and in the 17th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

IBB Top 10 Countries

IBB Top 10 Sectors

IBB Top 10 Holdings View All

IBB Summary Data

BlackRock
iShares
02/05/01
Open-Ended Fund
0.47%
$9.83B
$312.25M
0.06%

IBB Portfolio Data

$45.89B
-133.01
5.57
0.22%
12/21/17
160

IBB Index Data

Market Cap
NASDAQ - Listed
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to IBB

N/A
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

IBB Portfolio Management

0.47%
-0.3%
-0.18%
-0.44%

IBB Tax Exposures

20% / 39.6%
--
Qualified dividends
No

IBB Fund Structure

Open-Ended Fund
No
Yes
72% / 29%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
15:59:58312.5188
15:59:57312.51100
15:59:56312.439
15:59:53312.4874
15:59:03312.5023
15:58:46312.52100
15:58:45312.52175
15:58:02312.581
15:58:02312.581
15:57:52312.57100
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

IBB Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IBB. IBB is rated a 5 out of 5.

IBB Tradability

966,550
$312.25M
866,764
$270.88M
0.06%
$0.19
-0.01%
0.13% / -0.12%
None
100%
50,000
17.34
0%
0.3%
113,425
$310.81
5

IBB Geographic Exposure

IBBSegment Benchmark
99.48% 97.17%
-- 1.78%
-- 0.45%
0.52% 0.37%
-- 0.21%
-- 0.03%

IBBSegment Benchmark
99.48% 97.17%
-- 2.44%
0.52% 0.37%
99.48% / 0.52% 99.63% / 0.37%

IBB Performance Statistics

0.93
1
0.98
0.99
0.3%
Thomson Reuters US Biotechnology & Medical Research

IBB MSCI ESG Ratings

4.42 / 10
21.51
17.02
--
40.27%
19.08

IBB BENCHMARK COMPARISON

    IBB
    160 Holdings
    Segment Benchmark
    125 Constituents
    Shared Holdings
    93 (Count)
     
    50.67% (Weight)
IBBSegment Benchmark
52.32% 60.84%
29.63% 22.90%
16.09% 14.06%
1.95% 2.21%
146.49 -133.01
0.67% 0.43%
High High